1. Home
  2. HALO vs EPAM Comparison

HALO vs EPAM Comparison

Compare HALO & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • EPAM
  • Stock Information
  • Founded
  • HALO 1998
  • EPAM 1993
  • Country
  • HALO United States
  • EPAM United States
  • Employees
  • HALO N/A
  • EPAM N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • EPAM EDP Services
  • Sector
  • HALO Health Care
  • EPAM Technology
  • Exchange
  • HALO Nasdaq
  • EPAM Nasdaq
  • Market Cap
  • HALO 7.4B
  • EPAM 8.2B
  • IPO Year
  • HALO N/A
  • EPAM 2012
  • Fundamental
  • Price
  • HALO $54.54
  • EPAM $175.76
  • Analyst Decision
  • HALO Buy
  • EPAM Buy
  • Analyst Count
  • HALO 9
  • EPAM 16
  • Target Price
  • HALO $63.56
  • EPAM $229.00
  • AVG Volume (30 Days)
  • HALO 3.3M
  • EPAM 831.5K
  • Earning Date
  • HALO 05-06-2025
  • EPAM 05-08-2025
  • Dividend Yield
  • HALO N/A
  • EPAM N/A
  • EPS Growth
  • HALO 55.40
  • EPAM N/A
  • EPS
  • HALO 3.76
  • EPAM 7.15
  • Revenue
  • HALO $1,084,306,000.00
  • EPAM $4,864,167,000.00
  • Revenue This Year
  • HALO $25.77
  • EPAM $15.10
  • Revenue Next Year
  • HALO $18.01
  • EPAM $7.61
  • P/E Ratio
  • HALO $14.51
  • EPAM $24.60
  • Revenue Growth
  • HALO 25.64
  • EPAM 4.72
  • 52 Week Low
  • HALO $42.01
  • EPAM $138.15
  • 52 Week High
  • HALO $70.51
  • EPAM $269.00
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.48
  • EPAM 52.55
  • Support Level
  • HALO $52.43
  • EPAM $177.00
  • Resistance Level
  • HALO $54.26
  • EPAM $187.56
  • Average True Range (ATR)
  • HALO 3.42
  • EPAM 5.36
  • MACD
  • HALO -0.49
  • EPAM 0.60
  • Stochastic Oscillator
  • HALO 30.60
  • EPAM 58.52

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About EPAM EPAM Systems Inc.

EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.

Share on Social Networks: